Caroline Litchfield - EVP & CFO at Merck & Co., Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Evp & Cfo
Stock Symbol
MRK on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Caroline Litchfield - trading volume in the past year for Merck & Co., Inc.

Holdings reported by Caroline Litchfield for Merck & Co., Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 50,908 $6.39 M $125.50 Apr 30, 2024 Direct
Stock Option (Right to Buy) 49,805 Apr 30, 2024 Direct Common Stock
Restricted Stock Unit 0 May 1, 2023 Direct Common Stock

Transactions reported by Caroline Litchfield for Merck & Co., Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership